{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:21:17Z","timestamp":1787019677343,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2407-14-905","type":"journal-article","created":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T23:02:14Z","timestamp":1417561334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["An epidemiological study assessing the prevalence of human papillomavirus types in women in the Kingdom of Bahrain"],"prefix":"10.1186","volume":"14","author":[{"given":"Khairya","family":"Moosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel Salman","family":"Alsayyad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Quint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kusuma","family":"Gopala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"DeAntonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,3]]},"reference":[{"issue":"5","key":"5071_CR1","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/ijc.27711","volume":"132","author":"F Bray","year":"2013","unstructured":"Bray F, Ren JS, Masuyer E, Ferlay J: Estimates of global cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013, 132 (5): 1133-1145. 10.1002\/ijc.27711.","journal-title":"Int J Cancer"},{"key":"5071_CR2","unstructured":"Bruni L, Barrionuevo-Rosas L, Serrano B, Brotons M, Albero G, Cosano R, Mu\u00f1oz J, Bosch FX, de Sanjos\u00e9 S, Castellsagu\u00e9 X, ICO Information Centre on HPV and Cancer (HPV Information Centre): Human papillomavirus and related diseases in Bahrain. Summary Report 2014-08-22. [ http:\/\/www.hpvcentre.net\/statistics\/reports\/BHR.pdf ] Data Accessed: 28 November 2014"},{"key":"5071_CR3","unstructured":"Ministry of Health Bahrain: Ten years cancer incidence among nationals of the GCC States 1998\u20132007. Gulf Center for Cancer Control and Prevention, King Faisal Specialist Hospital and Research Center [ http:\/\/www.moh.gov.bh\/pdf\/publications\/GCC%20Cancer%20Incidence%202011.pdf ] Data Accessed: 28 November 2014"},{"issue":"2","key":"5071_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.12816\/0004484","volume":"36","author":"A Abduljabbar","year":"2014","unstructured":"Abduljabbar A, Al-Rawahi F, Faqihi F, Al-Khayat M, Al-Mahmeed M, Al-Khazali M, Al-Sayed N, AlGhaffar S, AlNasir F: Types and risk factors of cervical cancer. Bahrain Med Bulletin. 2014, 36 (2): 94-96. 10.12816\/0004484.","journal-title":"Bahrain Med Bulletin"},{"issue":"1","key":"5071_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999, 189 (1): 12-19. 10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.","journal-title":"J Pathol"},{"issue":"6","key":"5071_CR6","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Munoz","year":"2003","unstructured":"Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ: International Agency for Research on Cancer Multicenter Cervical Cancer Study G: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003, 348 (6): 518-527. 10.1056\/NEJMoa021641.","journal-title":"N Engl J Med"},{"issue":"11","key":"5071_CR7","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","volume":"11","author":"S de Sanjose","year":"2010","unstructured":"de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, et al: Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010, 11 (11): 1048-1056. 10.1016\/S1470-2045(10)70230-8.","journal-title":"Lancet Oncol"},{"issue":"4","key":"5071_CR8","first-page":"487","volume":"27","author":"AA Hajjaj","year":"2006","unstructured":"Hajjaj AA, Senok AC, Al-Mahmeed AE, Issa AA, Arzese AR, Botta GA: Human papillomavirus infection among women attending health facilities in the Kingdom of Bahrain. Saudi Med J. 2006, 27 (4): 487-491.","journal-title":"Saudi Med J"},{"issue":"5","key":"5071_CR9","doi-asserted-by":"publisher","first-page":"332","DOI":"10.4161\/hv.5.5.7211","volume":"5","author":"D Descamps","year":"2009","unstructured":"Descamps D, Hardt K, Spiessens B, Izurieta P, Verstraeten T, Breuer T, Dubin G: Safety of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine for cervical cancer prevention: a pooled analysis of 11 clinical trials. Hum Vaccin. 2009, 5 (5): 332-340. 10.4161\/hv.5.5.7211.","journal-title":"Hum Vaccin"},{"issue":"9686","key":"5071_CR10","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","volume":"374","author":"J Paavonen","year":"2009","unstructured":"Paavonen J, Naud P, Salmer\u00f3n J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, Hedrick J, Jaisamrarn U, Limson G, Garland S, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, Jenkins D, Hardt K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G, HPV PATRICIA Study Group: Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet. 2009, 374 (9686): 301-314. 10.1016\/S0140-6736(09)61248-4.","journal-title":"Lancet"},{"issue":"12","key":"5071_CR11","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.4161\/hv.7.12.18281","volume":"7","author":"MH Einstein","year":"2011","unstructured":"Einstein MH, Baron M, Levin MJ, Chatterjee A, Fox B, Scholar S, Rosen J, Chakhtoura N, Meric D, Dessy FJ, Datta SK, Descamps D, Dubin G, HPV-010 Study Group: Comparative immunogenicity and safety of human papillomavirus (HPV)-16\/18 vaccine and HPV-6\/11\/16\/18 vaccine: follow-up from months 12\u201324 in a Phase III randomized study of healthy women aged 18\u201345 years. Hum Vaccin. 2011, 7 (12): 1343-1358. 10.4161\/hv.7.12.18281.","journal-title":"Hum Vaccin"},{"issue":"51","key":"5071_CR12","doi-asserted-by":"publisher","first-page":"6630","DOI":"10.1016\/j.vaccine.2008.09.049","volume":"26","author":"T Verstraeten","year":"2008","unstructured":"Verstraeten T, Descamps D, David MP, Zahaf T, Hardt K, Izurieta P, Dubin G, Breuer T: Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines. Vaccine. 2008, 26 (51): 6630-6638. 10.1016\/j.vaccine.2008.09.049.","journal-title":"Vaccine"},{"issue":"1","key":"5071_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/bjc.2011.185","volume":"105","author":"X Castellsagu\u00e9","year":"2011","unstructured":"Castellsagu\u00e9 X, Mu\u00f1oz N, Pitisuttithum P, Ferris D, Monsonego J, Ault K, Luna J, Myers E, Mallary S, Bautista OM, Bryan J, Vuocolo S, Haupt RM, Saah A: End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24\u201345 years of age. Br J Cancer. 2011, 105 (1): 28-37. 10.1038\/bjc.2011.185.","journal-title":"Br J Cancer"},{"issue":"1","key":"5071_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S1470-2045(11)70286-8","volume":"13","author":"M Lehtinen","year":"2012","unstructured":"Lehtinen M, Paavonen J, Wheeler CM, Jaisamrarn U, Garland SM, Castellsagu\u00e9 X, Skinner SR, Apter D, Naud P, Salmer\u00f3n J, Chow SN, Kitchener H, Teixeira JC, Hedrick J, Limson G, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, De Carvalho NS, Germar MJ, Peters K, Mindel A, De Sutter P, Bosch FX, David MP, Descamps D, Struyf F, Dubin G, HPV PATRICIA Study Group: Overall efficacy of HPV-16\/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol. 2012, 13 (1): 89-99. 10.1016\/S1470-2045(11)70286-8.","journal-title":"Lancet Oncol"},{"issue":"3","key":"5071_CR15","doi-asserted-by":"publisher","first-page":"390","DOI":"10.4161\/hv.18865","volume":"8","author":"CM Roteli-Martins","year":"2012","unstructured":"Roteli-Martins CM, Naud P, De Borba P, Teixeira JC, De Carvalho NS, Zahaf T, Sanchez N, Geeraerts B, Descamps D: Sustained immunogenicity and efficacy of the HPV-16\/18 AS04-adjuvanted vaccine: up to 8.4 years of follow-up. Hum Vaccin Immunother. 2012, 8 (3): 390-397. 10.4161\/hv.18865.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"5071_CR16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S1470-2045(11)70287-X","volume":"13","author":"CM Wheeler","year":"2012","unstructured":"Wheeler CM, Castellsagu\u00e9 X, Garland SM, Szarewski A, Paavonen J, Naud P, Salmer\u00f3n J, Chow SN, Apter D, Kitchener H, Teixeira JC, Skinner SR, Jaisamrarn U, Limson G, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, Harper DM, Huh W, Hardt K, Zahaf T, Descamps D, Struyf F, Dubin G, Lehtinen M, HPV PATRICIA Study Group: Cross-protective efficacy of HPV-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol. 2012, 13 (1): 100-110. 10.1016\/S1470-2045(11)70287-X.","journal-title":"Lancet Oncol"},{"issue":"2","key":"5071_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jcv.2013.02.016","volume":"57","author":"DT Geraets","year":"2013","unstructured":"Geraets DT, van Baars R, Alonso I, Ordi J, Torne A, Melchers WJ, Meijer CJ, Quint WG: Clinical evaluation of high-risk HPV detection on self-samples using the indicating FTA-elute solid-carrier cartridge. J Clin Virol. 2013, 57 (2): 125-129. 10.1016\/j.jcv.2013.02.016.","journal-title":"J Clin Virol"},{"issue":"9","key":"5071_CR18","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1128\/JCM.00539-06","volume":"44","author":"LJ van Doorn","year":"2006","unstructured":"van Doorn LJ, Molijn A, Kleter B, Quint W, Colau B: Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR. J Clin Microbiol. 2006, 44 (9): 3292-3298. 10.1128\/JCM.00539-06.","journal-title":"J Clin Microbiol"},{"issue":"8","key":"5071_CR19","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1128\/JCM.37.8.2508-2517.1999","volume":"37","author":"B Kleter","year":"1999","unstructured":"Kleter B, van Doorn LJ, Schrauwen L, Molijn A, Sastrowijoto S, ter Schegget J, Lindeman J, ter Harmsel B, Burger M, Quint W: Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol. 1999, 37 (8): 2508-2517.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"5071_CR20","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ijc.24075","volume":"124","author":"P de Cremoux","year":"2009","unstructured":"de Cremoux P, de la Rochefordi\u00e8re A, Savignoni A, Kirova Y, Alran S, Fourchotte V, Plancher C, Thioux M, Salmon RJ, Cottu P, Mignot L, Sastre-Garau X: Different outcome of invasive cervical cancer associated with high-risk versus intermediate-risk HPV genotype. Int J Cancer. 2009, 124 (4): 778-782. 10.1002\/ijc.24075.","journal-title":"Int J Cancer"},{"issue":"3","key":"5071_CR21","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/jmv.21981","volume":"83","author":"R Al-Awadhi","year":"2011","unstructured":"Al-Awadhi R, Chehadeh W, Kapila K: Prevalence of human papillomavirus among women with normal cervical cytology in Kuwait. J Med Virol. 2011, 83 (3): 453-460. 10.1002\/jmv.21981.","journal-title":"J Med Virol"},{"issue":"1","key":"5071_CR22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5144\/0256-4947.2013.13","volume":"33","author":"NS Bondagji","year":"2013","unstructured":"Bondagji NS, Gazzaz FS, Sait K, Abdullah L: Prevalence of high-risk human papillomavirus infections in healthy Saudi women attending gynecologic clinics in the western region of Saudi Arabia. Ann Saudi Med. 2013, 33 (1): 13-17.","journal-title":"Ann Saudi Med"},{"issue":"2","key":"5071_CR23","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/LGT.0b013e31823a0108","volume":"16","author":"M Seoud","year":"2012","unstructured":"Seoud M: Burden of human papillomavirus-related cervical disease in the extended middle East and north Africa-a comprehensive literature review. J Low Genit Tract Dis. 2012, 16 (2): 106-120. 10.1097\/LGT.0b013e31823a0108.","journal-title":"J Low Genit Tract Dis"},{"issue":"12","key":"5071_CR24","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1086\/657321","volume":"202","author":"L Bruni","year":"2010","unstructured":"Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S: Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010, 202 (12): 1789-1799. 10.1086\/657321.","journal-title":"J Infect Dis"},{"issue":"7","key":"5071_CR25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","volume":"7","author":"S de Sanjose","year":"2007","unstructured":"de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, Bosch FX: Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007, 7 (7): 453-459. 10.1016\/S1473-3099(07)70158-5.","journal-title":"Lancet Infect Dis"},{"key":"5071_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1750-9378-2-12","volume":"2","author":"HS el-All","year":"2007","unstructured":"el-All HS, Refaat A, Dandash K: Prevalence of cervical neoplastic lesions and Human Papilloma Virus infection in Egypt: National Cervical Cancer Screening Project. Infect Agent Cancer. 2007, 2: 12-10.1186\/1750-9378-2-12.","journal-title":"Infect Agent Cancer"},{"key":"5071_CR27","unstructured":"Centers for Disease Control and Prevention: HPV Provider Survey: Knowledge, attitudes, and practices about genital HPV infection and related conditions. June 14, 2005. [ http:\/\/www.cdc.gov\/std\/hpv\/HPVProviderSurveyExecSum.pdf ] Data Accessed: 28 November 2014"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-905.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-14-905\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-905","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T09:40:27Z","timestamp":1598521227000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["5071"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-14-905","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"article-number":"905"}}